Identification of sepsis-associated encephalopathy biomarkers through machine learning and bioinformatics approaches.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Full primary article confirms transcriptomic ML identified 18 SAE candidate biomarkers, with a separate dataset and BV2-cell qPCR evidence; approve as candidate biology, not clinical biomarkers.
Technology: PMC Methods: three GEO datasets, WGCNA and Elastic Net/LASSO/RF/XGBoost; Results: 18 selected biomarkers, external GEO validation and in-vitro qPCR differential expression.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- PMC Methods: three GEO datasets, WGCNA and Elastic Net/LASSO/RF/XGBoost; Results: 18 selected biomarkers, external GEO validation and in-vitro qPCR differential expression.
- Limitation / still unknown
- Candidate biomarkers and BV2-cell qPCR do not establish clinical diagnostic performance or causal disease mechanisms.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11685593/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.